Skip to content

Author

Mark D. P. Willcox

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Advancements in peptidomimetics as a strategy against multidrug resistance: Fundamentals, rational design, resistance mechanisms, and artificial intelligence.

Antimicrobial peptides offer rapid, often membrane centered activity, but their therapeutic translation is limited by proteolytic instability, toxicity, reduced activity under physiological conditions, unfavourable pharmacokinetics, and manufacturing challenges. Peptidomimetics seek to retain the functional logic of an...

T. Ibisanmi, Ghayah Bahatheg, U. Urmi et al. · 0 citations
#protein folding Review Open access Sep 2026

Lab to codes: multimodel advanced AI-driven pipelines to drive antimicrobial peptide design for the post-antibiotic era

The rapid emergence of global antimicrobial resistance (AMR) has outpaced the development of new antimicrobial agents, necessitating transformative approaches such as AI-driven in-silico drug discovery. Antimicrobial peptides (AMPs) are promising alternatives due to their broad-spectrum bactericidal activity and limite...

Naveed Saleem, E. El-Omar, Naresh Kumar et al. · 0 citations
Review Open access Sep 2026

Recent progress in the structure–activity relationship of antibacterial peptoids

Peptoids are a new class of peptidomimetics that mimic the structure of AMPs, overcoming several of these drawbacks through resistance to proteolysis and efficient, low-cost synthesis of short sequences.

Ghayah Bahatheg, T. Ibisanmi, David Stc Black et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.